Menu
Explore a research direction
Cancer biology
research labs.
Explore labs that list cancer biology among their research interests, including work on how cancers arise and progress and how they might be treated. Each profile links to its official sources so you can check what a group actually studies before you decide whom to contact.
What to compare
When comparing groups in cancer biology, look at laboratory, computational and clinical components, and whether students take part in patient-related research. Ask how a new researcher would be involved and what preparation is expected.
Profiles appear here because their listed research keywords match this topic. Inclusion does not establish an open position. Check the official sources and any published application instructions before reaching out.
Prepare a research introduction ↗22 research-led lab profiles
Browse labs by their listed college affiliationAaron Quinlan Research Group
University of UtahAaron Quinlan · Professor and Chair of Human Genetics
Which changes in a genome matter for disease, and how can researchers find them efficiently? The group combines genetics and genomic technologies with computer science and machine learning to analyze genetic variation. Researchers develop software for identifying candidate variants in rare familial disease and detecting structural changes such as deletions, duplications and inversions. Another direction examines genomic changes involved in cancer evolution, treatment resistance and relapse. The lab also maintains practical tools for manipulating and comparing large sequencing datasets, including BEDTOOLS, GEMINI and LUMPY.
Albert Fornace Research Group
Georgetown UniversityAlbert Fornace · Professor
How do cells and tissues respond to radiation injury, including the particle radiation that astronauts meet in deep space? Albert Fornace's studies cover cell and tissue injury with relevance to radiobiology, cancer biology, immunology, metabolomics, toxicology, and microbiome research. The laboratory has extensive experience in radiation carcinogenesis and radiation injury, including particle radiation relevant to space radiation and radiation therapy. High-energy particles such as space radiation or neutrons are highly effective in generating senescent cells in vivo. The team has pioneered the use of omic approaches including metabolomics for stress signaling applications.
Arul M. Chinnaiyan Research Group
University of Michigan-Ann ArborArul M. Chinnaiyan · S.P. Hicks Endowed Professor of Pathology
Which genetic changes drive prostate cancer, and how can they be turned into tests and treatments for patients? Researchers in the group uncovered gene fusions joining TMPRSS2 with ETS family genes in most prostate cancers, the first causative fusion found in a common solid tumor. A clinical sequencing program called MI-Oncoseq profiles tumors from advanced cancer patients to support precision oncology decisions. Prostate cancer biomarkers characterized by the team include AMACR, EZH2, a sarcosine metabolite, and the long non-coding RNA Schlap1. A large part of the laboratory applies RNA sequencing to map long non-coding RNAs in cancer, including detailed studies of PCAT1, PCAT29 and PCA3.
David Beebe Research Group
University of Wisconsin-MadisonDavid Beebe · John D. MacArthur Professor & Claude Bernard Professor of Biomedical Engineering
How can engineered in vitro cellular systems recreate in vivo conditions to explain cell behavior? David Beebe's group takes a holistic approach to understanding cell behavior. The approach integrates in vitro cellular scale engineering to recapitulate important in vivo microenvironmental characteristics. These systems aim to provide biological insights, aid in diagnosis and treatment, and enhance discovery. Particular interests center around cancer biology and infectious disease, with broad potential application across cell biology.
David Haussler Research Group
University of California, Santa CruzDavid Haussler · Distinguished Professor
What genomic changes underlie human neural development differences and disease-associated variants? The Computational Genomics / Haussler Lab develops statistical and algorithmic methods to analyze genome, transcriptome, and comparative genomics data to study gene regulation and molecular evolution. Researchers apply hidden Markov models, stochastic grammars, and discriminative kernel methods to detect genomic patterns and cancer biomarkers across genomes. The lab uses CRISPR, human cerebral cortex organoids, and single-cell RNA-seq to functionally characterize neurodevelopmental genes altered in human evolution. They build and maintain web tools (UCSC Genome Browser, Xena) for large-scale genomic data sharing and comparative analysis across species.
Don Cleveland Research Group
University of California, San DiegoDon Cleveland · Professor
How do cells assemble the mitotic spindle and segregate chromosomes faithfully just before division? Don Cleveland is interested in the genes and proteins involved in this process, which is relevant to cancer because cancer cells mis-segregate chromosomes. The major pathway guarding against whole chromosome mis-segregation is the mitotic checkpoint, a cell cycle control mechanism. Starting from purified components, his efforts have reconstructed mitotic checkpoint signaling in vitro. Work on centrosomes identified how over-replication is blocked, with kinase-mediated, autoregulated instability of Plk4 limiting Plk4 activity to prevent centrosome amplification.
Elizabeth Purdom Research Group
University of California, BerkeleyElizabeth Purdom · Professor
How can statistical methods make sense of high-dimensional biological data? Elizabeth Purdom's research interests lie in developing statistical methods for high-dimensional data arising in the field of biology and genetics. She focuses on questions of robust estimation and hypothesis testing for high-throughput biological experiments, in particular gene expression microarrays. She is also interested in integration of heterogeneous sources of data, where the data can be multiple experimental platforms. Statistically, she is interested in questions of high-dimensional inference and multivariate analysis.
Gad Getz Research Group
Harvard UniversityGad Getz · Professor of Pathology
Which genetic changes in a tumor's DNA cause cancer, and how can computation reveal the mechanisms that created them? The group develops and applies genomic technologies and sequencing methods to analyze mutations found in cancer genomes. Characterization catalogs all genomic events and the mechanisms that created them during a cancer's clonal evolution, comparing DNA, RNA, and protein changes between tumor and normal samples from each patient. Interpretation then analyzes these data across patient cohorts to find altered genes and pathways that cause cancer or raise risk, and to define molecular subtypes of disease with their markers. Getz is a co-principal investigator in the Genome Data Analysis Center of The Cancer Genome Atlas project and a co-leader of the Pan-Cancer Analysis of Whole Genomes project.
Lawrence Boise Research Group
Emory UniversityLawrence Boise · Professor
How do therapeutic agents such as arsenicals and proteasome inhibitors kill myeloma cells? Lawrence Boise is a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He is a renowned researcher in the area of multiple myeloma. His research team studies how therapeutic agents such as arsenicals and proteasome inhibitors work to kill myeloma cells. He serves as associate director for education and training at Winship Cancer Institute of Emory University.
Ludmil Alexandrov Research Group
University of California, San DiegoLudmil Alexandrov · Professor
How do mutagenic and non-mutagenic processes drive cancer initiation and progression? Ludmil Alexandrov is a Professor at UC San Diego with joint appointments in the Department of Bioengineering and the Department of Cellular and Molecular Medicine. His work harnesses the information in large-scale omics datasets to deepen understanding of these processes. He aims to use this knowledge to identify novel cancer prevention strategies and to engineer innovative approaches for targeted treatment. He is also developing next generation artificial intelligence approaches to address inequalities in precancer interception, cancer diagnosis, and cancer care.
Marc Vidal Research Group
Harvard UniversityMarc Vidal · Professor, Genetics, Harvard Medical School
How are protein interactions organized at the scale of the whole cell? The research asks whether there are global principles that organize such complex networks of interactions in the cell. The research uses interactome modeling, the mapping and systematic characterization of protein-protein interactions at proteome scale. The work includes mapping interactions at proteome scale for human and for model organisms, as well as interactions between viral proteins and host proteins. The research also asks how such organizational principles are disrupted in human disease.
Michael A. Hollingsworth Research Group
University of Nebraska Medical CenterMichael A. Hollingsworth · Professor
Hollingsworth investigates pancreatic disease through the biology of epithelial cells and mucin-associated molecules. His laboratory studies MUC1, including its expression and processing in normal cells compared with pancreatic cancer and other disease conditions. Research combines molecular biology, biochemistry, cell biology, and immunology, while developing antibodies and tumor-vaccine reagents that target tumor-associated mucin antigens. Other work supports discovery and validation of biomarkers for early pancreatic disease. The group connects detailed molecular mechanisms with diagnostic and immunotherapy research, making the transition from normal tissue biology to tumor behavior a central question.
Nanomedicines and Translational Research Laboratory
University of Nebraska Medical CenterRam I. Mahato · Professor
Mahato investigates how a therapy reaches the tissue where it is needed. His Nanomedicines and Translational Research Laboratory develops micelles, nanoparticles, polymers, and lipid-based systems for delivering drugs and nucleic acids, including siRNA and miRNA. Projects examine cancer, liver disease, and type 1 diabetes, alongside approaches to drug resistance and disease-related signaling. The group studies how delivery-system components affect drug deposition, tumor vessels, and surrounding tissue. This connects chemistry and formulation design with biological evaluation, aiming to improve targeted delivery and reduce unwanted effects on healthy tissue.
Nils Gehlenborg Research Group
Harvard UniversityNils Gehlenborg · Professor
How can computational techniques and interfaces help scientists and clinicians interact with biomedical data? Tight integration of algorithmic approaches from biomedical informatics with advanced data visualization is central to his efforts. He is developing tools to visualize heterogeneous data from large-scale cancer genomics studies such as The Cancer Genome Atlas. His work includes integrating visual and computational approaches to support sense-making in biology. He also uses software to support reproducible collaborative research in epigenomics and genomics.
Roberto Zoncu Research Group
University of California, BerkeleyRoberto Zoncu · Professor of Molecular Therapeutics
How do consumed nutrients regulate growth and homeostasis? The lab focuses on the lysosome as its model system for studying how cells sense nutrients. The page describes the lysosome as emerging as a key signaling node that relays nutrient availability to mechanistic Target of Rapamycin Complex 1 (mTORC1). Methods named on the page include advanced live cell microscopy and in vitro biochemical assays. One current project is titled mechanisms of nutrient signal integration at the lysosome.
Sankar Ghosh Research Group
Columbia UniversitySankar Ghosh · Silverstein and Hutt Family Professor of Microbiology and Immunology
How does NF-kB, a transcription factor, control immune response and inflammation? Sankar Ghosh is best known for his work on NF-kB and its regulation, and it is a transcription factor that the page describes as central to immune response and inflammation. His research has advanced understanding of NF-kB regulation and function, including the cloning of NF-kB and IkB proteins. He chairs the Department of Microbiology and Immunology at Columbia University Irving Medical Center, where he is also a named professor.
Sarah Spiegel Research Group
Virginia Commonwealth UniversitySarah Spiegel · Professor
A lipid can be much more than a structural part of a cell: it can carry a signal that changes cell behavior. Spiegel investigates sphingosine-1-phosphate, or S1P, and the enzymes that produce it. Her laboratory examines how this signaling system connects inflammation with cancer progression, metastasis, obesity, and metabolic and liver diseases. The work brings lipid metabolism and signal transduction together around mechanisms of disease. Researchers interested in biochemical pathways can explore how a small signaling molecule influences several distinct biological processes and why those connections matter for potential therapeutic targets.
Scott Gerber Research Group
University of RochesterScott Gerber · Associate Professor, Surgery/Research
How can immune cells be re-activated to attack and eradicate tumors? Scott Gerber's laboratory focuses on reversing the process by which tumor cells transform immune cells to elicit tumor-promoting functions. The work uses immunotherapy, described on the page as a new line of cancer treatment, to enhance the body's own immune system to fight cancer. The lab focuses on understanding the complexities of the tumor microenvironment to identify factors that promote tumor growth and to develop therapies that counteract them. One goal of the laboratory is to enhance the efficacy of radiotherapy by targeting and stimulating immune cells.
Sidi Chen Research Group
Yale UniversitySidi Chen · Associate Professor of Genetics
Which genes and cell-intrinsic factors control anti-tumor immunity in vivo? The Chen lab performs genome-scale in vivo CRISPR and CRISPRa screens in T cells and tumors to discover regulators of T cell infiltration, degranulation, and tumor immune evasion. The group develops AAV- and CRISPR-based engineering platforms (for example MAEGI and AAV-Cpf1 KIKO) to create and test immune-gene and CAR-T engineering strategies in mouse tumor models. Researchers combine high-throughput genetic screens with precision in vivo cancer models to map tumor-intrinsic suppressors and immune modulators. Technology development includes spatial and scalable perturbation methods to enable therapeutic target discovery.
Tomi Akinyemiju Research Group
Duke UniversityTomi Akinyemiju · Professor in Population Health Sciences
How do social and biological factors contribute to cancer health disparities? Tomi Akinyemiju is a Professor of Population Health Sciences, Global Health and Ob/Gyn with expertise in cancer epidemiology, cancer biology, global health, and health disparities. Her research focuses on disentangling the role of race as a social construct and race-associated biological mechanisms that contribute to cancer disparities. She works with community-based organizations, policy makers, providers, health system leadership, and leaders from diverse communities to develop evidence-based interventions to advance health equity. She is also a Research Professor of Global Health at Duke.
Ulrich Bierbach Research Group
Wake Forest UniversityUlrich Bierbach · Professor
Bierbach designs drug candidates that combine organic molecules with metal-based chemistry. His laboratory investigates platinum-acridine hybrid anticancer agents, linking chemical structure with biological activity and mechanisms of action. Research listed by Wake Forest includes identifying DNA targets, examining how membrane transport influences activity, and studying relationships between gene expression and drug sensitivity. The group also explores delivery formulations, including liposomal approaches. This is a preclinical research setting for people interested in medicinal and inorganic chemistry, where synthesizing a compound is paired with investigating how it reaches and affects cancer cells.
Zhong-Yin Zhang Research Group
Purdue University West LafayetteZhong-Yin Zhang · Distinguished Professor of Medicinal Chemistry
How can protein tyrosine phosphatases be targeted to control disease progression? The research spans chemistry and biology with an emphasis on protein tyrosine phosphatases (PTPs), enzymes that regulate cellular processes. These enzymes remove phosphoryl groups from tyrosine phosphorylated proteins. Abnormal PTP activity leads to aberrant cellular signaling linked to the development of cancer, diabetes and obesity, neurodegenerative and autoimmune disorders, and infectious diseases. Zhong-Yin Zhang is also Director of the Purdue Institute for Drug Discovery.
Showing 1–22 of 22 labs